Literature DB >> 31535760

The patient journey: a voyage from diagnosis to hidradenitis suppurativa multidisciplinary unit.

A Chiricozzi1,2, G Micali3, S Veraldi4.   

Abstract

BACKGROUND: Hidradenitis suppurativa (HS) is an inflammatory, recurrent and debilitating chronic skin disease that is often worsened by comorbidities, with a destructive impact on the social and working life of the patient. The low awareness of patients and clinicians regarding HS, together with weak coordination between specialists who manage the clinical care of these patients, may result in a burdening diagnostic and therapeutic delay, lowering efficacy of therapies and worsening prognosis and patients' QoL.
OBJECTIVES: To rule out these critical aspects, a HS-Multidisciplinary Unit with a hierarchical organization is proposed.
METHODS: Based on previously published models of a multidisciplinary unit, a hierarchical structure of a HS-dedicated multidisciplinary unit was designed.
RESULTS: In this model, an operational core constituted by four healthcare professionals constantly working as team, is supported by a large panel of consultants, local dermatologists and general practitioners, helping in HS patient management.
CONCLUSIONS: This standardization would imply an optimization of professional resources, an amelioration of patient's quality of life, and a shortening of patient journey.
© 2019 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2019        PMID: 31535760     DOI: 10.1111/jdv.15850

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  2 in total

1.  Comprehensive approach to managing hidradenitis suppurativa patients.

Authors:  Erin K Collier; Jennifer L Hsiao; Vivian Y Shi; Haley B Naik
Journal:  Int J Dermatol       Date:  2020-04-06       Impact factor: 2.736

Review 2.  Therapies for hidradenitis suppurativa: a systematic review with a focus on Brazil.

Authors:  Maria Cecilia Rivitti-Machado; Renata Ferreira Magalhães; Roberto Souto da Silva; Gleison V Duarte; Fabiana Zs Bosnich; Roberto Gaspar Tunala; Francisco José Forestiero
Journal:  Drugs Context       Date:  2022-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.